AGP Picks
View all

AGP Executive Report

Last update: 19 hours ago

Biotech & Oncology: Orion Pharma reported first Phase 1/2 results for TEAD inhibitor ODM-212 in advanced solid tumors, with early responses and manageable safety. Cancer Care Tech: BioNTech and Bristol Myers Squibb shared interim ROSETTA Lung-02 Phase 2 data for pumitamig (PD-L1xVEGF-A) plus chemo in first-line NSCLC, showing strong activity across PD-L1 levels. Radiation Breakthrough: A study on tile-based radiation therapy (radioactive collagen tiles) in brain metastases claims major gains in local control and survival versus standard postoperative stereotactic radiation. Cybersecurity: Multiple US healthcare breaches exposed Social Security numbers and medical records, including a major New York City Health and Hospitals incident affecting millions. AI in Research: Google opened public registration for Co-Scientist’s hypothesis tool, following Nature publication of lab-validated results. Climate & Law: Switzerland raised the bar for climate claims, pushing companies to avoid greenwashing and “greenhushing.” Energy & Industry: Caudal Energy secured £4.3m for mid-flow tidal power testing, aiming for commercial deployment by 2028. Public Health Policy: Trump signed an order directing the CDC to align childhood vaccine scheduling with a prior HHS assessment calling for fewer shots. Workforce & Education: UW-Madison will debut free metals casting and CNC workforce hubs, while Malaysia’s UPSI plans a mountaineering school to cut hiking incidents. Environment & Health: Students in Sydney removed Agent Orange-related chemicals from a waterway, and researchers explored kimchi bacteria as a possible nanoplastic absorber.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
May 29, 2026

Influential Women spotlights Charles River scientist Meenakshi Agarwal

EIN Presswire

fallback image
May 29, 2026

Donna K. Alexander profile spotlights decades of engineering leadership

EIN Presswire

fallback image
May 29, 2026

Nature.com spotlights Saisei Pharma’s MAF longevity research

EIN Presswire

fallback image
May 29, 2026

XtalPi pushes AI-driven R&D into autonomous experimentation

EIN Presswire


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
China’s biotech ascent forces US industry to choose: Is the country an ally or an existential threat?

China’s biotech ascent forces US industry to choose: Is the country an ally or an existential threat?

Science & Spiritual Power Behind Surya Arghya |Mind & Body Secrets Explained| Ft. Acharya Pratishtha

Science & Spiritual Power Behind Surya Arghya |Mind & Body Secrets Explained| Ft. Acharya Pratishtha

From science fiction to warzone: Two-year-old tech startup wants to put humanoid robots in US military

From science fiction to warzone: Two-year-old tech startup wants to put humanoid robots in US military

Amador High alum fights on through rare medical diagnosis to earn degree

Amador High alum fights on through rare medical diagnosis to earn degree

Hall Neighborhood House helps Bridgeport teen on track to becoming a medical doctor

Hall Neighborhood House helps Bridgeport teen on track to becoming a medical doctor

Increase Science Literacy — Use R&D Labels On All Products

Increase Science Literacy — Use R&D Labels On All Products


fallback image
May 30, 2026

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

GlobeNewswire, Inc.

fallback image
May 30, 2026

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

GlobeNewswire, Inc.

fallback image
May 30, 2026

How Riccio Pharmacy Makes Online Medicine Delivery Easier For Patients?

GlobeNewswire, Inc.

fallback image
May 29, 2026

Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis

GlobeNewswire, Inc.

fallback image
May 29, 2026

Kane Biotech Announces Grant of Stock Options

GlobeNewswire, Inc.

fallback image
May 29, 2026

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: 'The Next Step for Humanity as a Whole': China’s Space Race With the US Heats up
Play
'The Next Step for Humanity as a Whole': China’s Space Race With the US Heats up
YouTube video thumbnail: Apple Is Overhauling Siri to Bring AI to the Masses
Play
Apple Is Overhauling Siri to Bring AI to the Masses
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Why the Spacex IPO Is Unlike Any Other
Play
Why the Spacex IPO Is Unlike Any Other
YouTube video thumbnail: Neutrinos: Do They Reveal the Secrets of the Universe?
Play
Neutrinos: Do They Reveal the Secrets of the Universe?

Video Title

Sign up for:

Technology News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Sign up for:

Technology News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.